Myriad Genetics (MYGN) EBITDA Margin Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -2,667.00 |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 37.00 |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 39.00 |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 8.00 |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 110.00 |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 376.00 |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -57.00 |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 340.00 |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 151.00 |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | -52.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.00 |
| Dec 31, 2025 | 1,580.00 |
| Sep 30, 2025 | -195.00 |
| Jun 30, 2025 | -13,722.00 |
| Mar 31, 2025 | -101.00 |
| Dec 31, 2024 | -255.00 |
| Sep 30, 2024 | 2,194.00 |
| Jun 30, 2024 | 4,470.00 |
| Mar 31, 2024 | 1,501.00 |
| Dec 31, 2023 | 1,339.00 |
| Sep 30, 2023 | -255.00 |
| Jun 30, 2023 | -5,203.00 |
| Mar 31, 2023 | -1,328.00 |
| Dec 31, 2022 | -256.00 |
| Sep 30, 2022 | 1,899.00 |
| Jun 30, 2022 | 105.00 |
| Mar 31, 2022 | 1,145.00 |
| Dec 31, 2021 | 248.00 |
| Sep 30, 2021 | -2,049.00 |
| Jun 30, 2021 | 6,230.00 |